Connection
Matthew Ellis to Recurrence
This is a "connection" page, showing publications Matthew Ellis has written about Recurrence.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.045 |
|
|
|
-
Suman VJ, Ellis MJ, Ma CX. The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancer. Chin Clin Oncol. 2015 Sep; 4(3):34.
Score: 0.022
-
Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med Genomics. 2015 Aug 22; 8:54.
Score: 0.022